Loading clinical trials...
Loading clinical trials...
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: The Pilot Study
Conditions
Interventions
Apixaban
Rivaroxaban
Locations
4
Canada
University of Alberta
Edmonton, Alberta, Canada
Hamilton General Hospital
Hamilton, Ontario, Canada
The Ottawa Hospital - General Campus
Ottawa, Ontario, Canada
Hôtel-Dieu de Sherbrooke
Sherbrooke, Quebec, Canada
Start Date
May 1, 2016
Primary Completion Date
November 1, 2017
Completion Date
February 1, 2018
Last Updated
November 17, 2025
NCT06189313
NCT07015905
NCT03728166
NCT07310693
NCT07288632
NCT06451003
Lead Sponsor
Ottawa Hospital Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions